Dropia-Met contains a combination of Dropia-Met and repaglinide. Dropia-Met and repaglinide are oral diabetes medications that help control blood sugar levels. Repaglinide works by causing the pancreas to produce insulin. Dropia-Met works by decreasing glucose (sugar) production in the liver and decreasing absorption of glucose by the intestines.
Dropia-Met is used to improve blood sugar control in adults with.
Dropia-Met is not for treating type 1 diabetes.